Tag: Vaccines

WHO expresses concern over measles outbreak in Europe

who
WHO is working closely with Member States currently facing outbreaks to implement response measures, including enhanced routine and supplemental immunization.

Russia may start using own quadrivalent influenza vaccine from 2019

popova
The Head of Rospotrebnadzor noted that by September 1, about 50% of the required volume of vaccines would be delivered to the regions of the Russian Federation.

Scandal over low-quality vaccines flares out in China

vaccine
The Jilin Food and Drug Administration revealed on its website that the second-largest drug manufacturer - Changchun Changsheng Life Sciences, in China provided defective vaccines for newborns.

Russia will introduce immunization against pneumococcal disease

influenza vaccine
Vaccination of adults over 55 years old against pneumococcal disease will be included in the National Immunization Schedule in 2020, said the Head of the Health Protection Committee at the State Duma.

EEC changed rules for registration of vaccines and use of GMP certificates

EAEU
The Council of the Eurasian Economic Commission (EEC) has amended the rules for registration and expert examination of medicinal products for human use in the Eurasian Economic Union.

European Commission calls for cooperation on vaccine preventable diseases

European-Commission
European Commission (EC) issued a set of recommendations for how the EU can strengthen cooperation in the fight against diseases that can be prevented by vaccines.

WHO started anti-cholera vaccination campaign in Yemen

who
The World Health Organization (WHO), in cooperation with Yemeni local health authorities, has launched a wide-scale anti-cholera vaccination campaign in South Yemen.

EMA published its current recommendations for the influenza vaccines

influenza vaccine
The European Medicines Agency (EMA) has issued the EU recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from autumn 2018.

Steering Group published their Manifesto for influenza vaccination in EU

influenza vaccine
The Steering Group on Influenza Vaccination has released their Manifesto calling for more action to increase seasonal influenza vaccination coverage rates in Europe to reduce the unacknowledged burden of this disease.

Nemaura Pharma moves forward with unique transdermal drug delivery technology

scientist
UK biotech company Nemaura Pharma has made significant progress in the reformulation of liquid vaccines administered through the skin using its solid dose delivery system, Micro-Patch

WHO approved Shantha Biotechnics cholera vaccine

who
Shantha Biotechnics, an affiliate of Sanofi Pasteur, has received approval from the World Health Organisation (WHO) for Shanchol, its oral cholera vaccine. The approval is for use at temperatures as h...

Sanofi Pasteur will pay $27.8 million to Philippines for the dengue vaccine

malaria vaccine
French pharmaceutical giant Sanofi agreed to reimburse the Philippine government for leftover doses of an anti-dengue vaccine whose use was suspended due to health concerns, the two parties said

Batavia Biosciences joins the international effort to develop a new polio vaccine

polio vaccine
Batavia Biosciences announced its partnership with an international consortium coordinated by PATH, aiming to develop and manufacture safer novel oral poliovirus vaccines

Sinovac Biotech gets a positive opinion from WHO on its Hepatitis A vaccine

vaccine
Sinovac Biotech announced that it has received a positive decision from the World Health Organization on the acceptability of its hepatitis A vaccine product

Yellow fever vaccine is the top Russian export product

chumakov
In January - October, 2017, the Russian exports of medicinal products (excluding exports to EAEU) amounted to 16.7 billion rubles (including customs duties)

Bavarian Nordic achieved contract for vaccines supply for U.S. Government

vaccine
Bavarian Nordic, a Danish biotech, announced the award of a sole source contract from the Biomedical Advanced Research and Development Authority